Your browser doesn't support javascript.
loading
Complement inhibitor CSMD1 modulates epidermal growth factor receptor oncogenic signaling and sensitizes breast cancer cells to chemotherapy.
Gialeli, Chrysostomi; Tuysuz, Emre Can; Staaf, Johan; Guleed, Safia; Paciorek, Veronika; Mörgelin, Matthias; Papadakos, Konstantinos S; Blom, Anna M.
Afiliação
  • Gialeli C; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Tuysuz EC; Experimental Cardiovascular Research Group, Department of Clinical Sciences, Lund University, Malmö, Sweden.
  • Staaf J; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Guleed S; Division of Oncology, Department of Clinical Sciences Lund, Lund University, Medicon Village, Lund, Sweden.
  • Paciorek V; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Mörgelin M; Department of Translational Medicine, Lund University, Malmö, Sweden.
  • Papadakos KS; Colzyx AB, Lund, Sweden.
  • Blom AM; Department of Translational Medicine, Lund University, Malmö, Sweden.
J Exp Clin Cancer Res ; 40(1): 258, 2021 Aug 17.
Article em En | MEDLINE | ID: mdl-34404439
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Resistencia a Medicamentos Antineoplásicos / Proteínas Supressoras de Tumor / Proteínas de Membrana / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Resistencia a Medicamentos Antineoplásicos / Proteínas Supressoras de Tumor / Proteínas de Membrana / Antineoplásicos Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article